Vivo Opportunity Fund Holdings L.P. 13D and 13G filings for InMed Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-06-10 9:32 pm Purchase | 2026-05-19 | 13D | INMED PHARMACEUTICALS INC INM | Vivo Opportunity Fund Holdings L.P. | 718,444 21.700% | 718,444 (New Position) | Filing |